Korea reached an agreement to buy more Covid-19 vaccine for 23 million people
South Korean Prime Minister Chung Sye-kyun said today, February 16, that the country has just reached an agreement to buy Covid-19-resistant vaccine for 23 million people.
|In the South Korean agreement to buy vaccines for 23 million people, vaccine development company Novavax will provide vaccines to 20 million people, the rest will be handled by multinational pharmaceutical company Pfizer. Photo: Shutterstock|
Prime Minister Chung Sye-kyun’s news came a day after officials decided to scale down the initial vaccination plan, citing delays in vaccine batches and concerns about vaccination effectiveness.
Prime Minister Chung Sye-kyun added that the South Korean government’s vaccine deals include doses of vaccine from Novavax Vaccine Development Company (USA) that is enough for 20 million people and vaccines from multinational pharmaceutical company Pfizer. (US) for 3 million people, thereby increasing vaccination coverage to 79 million people.
“The government has been working hard to secure an early supply of vaccines, but increasingly uncertain about vaccination plans in the first half of the year due to manufacturing problems among global pharmaceutical manufacturers and international competition. in the vaccine approach, ”Prime Minister Chung Sye-kyun emphasized at an online meeting.
Novavax recently announced that it has signed an agreement to license South Korean manufacturer SK Bioscience to produce 40 million doses of vaccine for South Korea.
With a population of 52 million, South Korea has previously secured enough vaccines for 56 million people from support from the global vaccine-sharing program COVAX and reached agreements with pharmacies: Pfizer, Moderna, AstraZeneca, and Johnson & Johnson. Accordingly, Korea will activate the vaccination campaign for medical staff and the elderly on February 26.
South Korean officials on Feb. 15 said the country withdrew its previous decision and will not give AstraZeneca vaccine to people aged 65 and over, due to fears that there are insufficient data on the effectiveness of the vaccine for people aged 65 years. .
The Korean government has cut its first quarter vaccination target of 2021 from 1.3 million to less than 760,000, on the grounds that vaccine shipments from the COVAX program have been delayed.
Director of the Korea Agency for Disease Control and Prevention (KDCA), Jeong Eun-kyeong, said that the adjustments to the vaccination plan in the first quarter of 2021 will not affect the target of “community immunity” at the country next November, although some independent health experts are skeptical of the feasibility of this goal.
South Korean Prime Minister Chung Sye-kyun said, the contract to add 6 million doses of vaccine signed with pharmaceutical company Pfizer will help Korea achieve the goal of “community immunity”. In addition, the pharmaceutical company has agreed to delay the delivery of an additional 1 million doses of vaccine to the second quarter of 2021.
In the latest development of Covid-19 epidemic in Korea, the Korea Agency for Disease Control and Prevention (KDCA) recorded an additional 457 cases of Covid-19 infection as of midnight February 15, hitting The mark of daily infections increased again to the 400 mark in the last 4 days after the Tet holiday.
South Korea has so far confirmed a total of 84,325 Covid-19 infections with 1,534 deaths from the virus.